{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T03:02:42Z","timestamp":1792638162068,"version":"4.5.0"},"reference-count":145,"publisher":"Informa UK Limited","issue":"8","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Investigational Drugs"],"published-print":{"date-parts":[[2024,8,2]]},"DOI":"10.1080\/13543784.2024.2377319","type":"journal-article","created":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T13:53:38Z","timestamp":1720619618000},"page":"757-773","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":7,"title":["Investigational and emerging gastric inhibitory polypeptide (GIP) receptor-based therapies for the treatment of obesity"],"prefix":"10.1080","volume":"33","author":[{"given":"Robert H.","family":"Gaffey","sequence":"first","affiliation":[{"name":"Comprehensive Weight Control Center, Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, Weill Cornell Medicine, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afua K.","family":"Takyi","sequence":"additional","affiliation":[{"name":"Comprehensive Weight Control Center, Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, Weill Cornell Medicine, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alpana","family":"Shukla","sequence":"additional","affiliation":[{"name":"Comprehensive Weight Control Center, Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, Weill Cornell Medicine, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,7,17]]},"reference":[{"key":"e_1_3_4_3_1","unstructured":"World Obesity Atlas. 2023."},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.peptides.2023.170939"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2023.2192865"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00387"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-med-043021-014919"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.07.033"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2307563"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.metop.2023.100236"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.5b00726"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrn.2018.8"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.1992.tb01464.x"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.physbeh.2011.12.001"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/bph.13384"},{"key":"e_1_3_4_16_1","volume-title":"Costanzo physiology","author":"Costanzo L","year":"2021","unstructured":"Costanzo L. Costanzo physiology. 7th ed. Philadelphia: Elsevier, Inc; 2021.","edition":"7"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00492251"},{"key":"e_1_3_4_18_1","volume-title":"Physiology, gastric inhibitory peptide","author":"Gupta K","year":"2023","unstructured":"Gupta K, Raja A. Physiology, gastric inhibitory peptide. Treasure Island (FL): StatPearls; 2023."},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1210\/edrv-16-3-390"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2007.03.054"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-021053"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(15)00482-9"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-81771-7_1"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-37-5-826"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-69-3-654"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1210\/endo.133.6.8243312"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2021.01.015"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/0303-7207(95)03701-2"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI116186"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00401145"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.87.3.8355"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1210\/endo-103-2-610"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-3644"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-008-1195-5"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00429703"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(87)81430-8"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI112855"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-0115(03)00111-3"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.1025-07.2007"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)36628-1"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI1349"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-0605"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-023-05956-x"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-018-0016-2"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.12488"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2017.07.011"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.2337\/dbi19-0005"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2013.09.002"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-002-0878-6"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc19-0578"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.53.suppl_3.S220"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.2337\/db13-1627"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0024-3205(99)00314-8"},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm727"},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-017-0011-x"},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aat3392"},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2018.12.001"},{"key":"e_1_3_4_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2022.101638"},{"key":"e_1_3_4_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2019.07.013"},{"key":"e_1_3_4_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2018.01.040"},{"key":"e_1_3_4_61_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18751-8"},{"key":"e_1_3_4_62_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcpt.13289"},{"key":"e_1_3_4_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2016.09.009"},{"key":"e_1_3_4_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2015.07.001"},{"key":"e_1_3_4_65_1","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa327"},{"key":"e_1_3_4_66_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.13764"},{"key":"e_1_3_4_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2017.03.018"},{"key":"e_1_3_4_68_1","doi-asserted-by":"publisher","DOI":"10.1039\/C9SC02079A"},{"key":"e_1_3_4_69_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03941-2"},{"key":"e_1_3_4_70_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20143532"},{"key":"e_1_3_4_71_1","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.140532"},{"key":"e_1_3_4_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.regpep.2007.02.006"},{"key":"e_1_3_4_73_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-010-1684-1"},{"key":"e_1_3_4_74_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-018-0093-z"},{"key":"e_1_3_4_75_1","doi-asserted-by":"publisher","DOI":"10.1301\/nr.2007.jun.S7-S12"},{"key":"e_1_3_4_76_1","doi-asserted-by":"publisher","DOI":"10.1677\/joe.0.1300267"},{"key":"e_1_3_4_77_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M609088200"},{"key":"e_1_3_4_78_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI110335"},{"key":"e_1_3_4_79_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2019.08.006"},{"key":"e_1_3_4_80_1","doi-asserted-by":"publisher","DOI":"10.2337\/db17-0480"},{"key":"e_1_3_4_81_1","doi-asserted-by":"publisher","DOI":"10.1038\/ijo.2008.148"},{"key":"e_1_3_4_82_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2007.09.005"},{"key":"e_1_3_4_83_1","doi-asserted-by":"publisher","DOI":"10.2337\/db21-1166"},{"key":"e_1_3_4_84_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2016-1933"},{"key":"e_1_3_4_85_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3997"},{"key":"e_1_3_4_86_1","doi-asserted-by":"publisher","DOI":"10.2337\/diab.28.12.1141"},{"key":"e_1_3_4_87_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.1985.249.6.E603"},{"key":"e_1_3_4_88_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M111.289009"},{"key":"e_1_3_4_89_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0040156"},{"key":"e_1_3_4_90_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1401149"},{"key":"e_1_3_4_91_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.14174"},{"key":"e_1_3_4_92_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2021.101261"},{"key":"e_1_3_4_93_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2022.101550"},{"key":"e_1_3_4_94_1","doi-asserted-by":"publisher","DOI":"10.1042\/bj2520843"},{"key":"e_1_3_4_95_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2022.102682"},{"key":"e_1_3_4_96_1","doi-asserted-by":"publisher","DOI":"10.1530\/JOE-23-0361"},{"key":"e_1_3_4_97_1","doi-asserted-by":"publisher","DOI":"10.1016\/0196-9781(94)90016-7"},{"key":"e_1_3_4_98_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2017.06.031"},{"key":"e_1_3_4_99_1","doi-asserted-by":"publisher","DOI":"10.33549\/physiolres.932151"},{"key":"e_1_3_4_100_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI126107"},{"key":"e_1_3_4_101_1","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.164921"},{"key":"e_1_3_4_102_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2020.02.006"},{"key":"e_1_3_4_103_1","doi-asserted-by":"publisher","DOI":"10.1080\/21688370.2023.2292461"},{"key":"e_1_3_4_104_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3007218"},{"key":"e_1_3_4_105_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.13024"},{"key":"e_1_3_4_106_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.13025"},{"key":"e_1_3_4_107_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2018.09.009"},{"key":"e_1_3_4_108_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)01324-6"},{"key":"e_1_3_4_109_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2116506119"},{"key":"e_1_3_4_110_1","doi-asserted-by":"publisher","DOI":"10.1038\/s42255-023-00811-0"},{"key":"e_1_3_4_111_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2206038"},{"key":"e_1_3_4_112_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)01200-X"},{"key":"e_1_3_4_113_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02597-w"},{"key":"e_1_3_4_114_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.24945"},{"key":"e_1_3_4_115_1","volume-title":"Lilly reports strong fourth-quarter 2023 financial results and provides 2024 guidance [internet]","year":"2024","unstructured":"Lilly reports strong fourth-quarter 2023 financial results and provides 2024 guidance [internet]. (Indiana)polis: PRNewswire; 2024 Feb 6; [8]. Available from: investor.lilly.com\/node\/50281\/pdf"},{"key":"e_1_3_4_116_1","unstructured":"McDermid E. A quick guide to the SURPASS and SURMOUNT trials: medicine matters diabetes. 2020 [cited 2024 Feb 22]. Available from: https:\/\/diabetes.medicinematters.com\/en-GB\/tirzepatide\/type-2-diabetes\/a-quick-guide-to-the-surpass-and-surmount-trials\/18478154"},{"key":"e_1_3_4_117_1","doi-asserted-by":"publisher","DOI":"10.2337\/db23-75-LB"},{"key":"e_1_3_4_118_1","doi-asserted-by":"publisher","DOI":"10.2337\/db23-774-P"},{"key":"e_1_3_4_119_1","unstructured":"Viking therapeutics announces positive top-line results from phase 2 VENTURE trial of dual GLP-1\/GIP receptor agonist VK2735 in patients with obesity [internet]. San Diego: PRNeswire; 2024 Feb 27. Available from: https:\/\/ir.vikingtherapeutics.com\/2024-02-27-Viking-Therapeutics-Announces-Positive-Top-Line-Results-from-Phase-2-VENTURE-Trial-of-Dual-GLP-1-GIP-Receptor-Agonist-VK2735-in-Patients-with-Obesity"},{"key":"e_1_3_4_120_1","unstructured":"Viking therapeutics announces results from phase 1 clinical trial of oral tablet formulation of dual GLP-1\/GIP receptor agonist VK2735 [Internet]. 2024 Mar 26. Available from: https:\/\/ir.vikingtherapeutics.com\/2024-03-26-Viking-Therapeutics-Announces-Results-from-Phase-1-Clinical-Trial-of-Oral-Tablet-Formulation-of-Dual-GLP-1-GIP-Receptor-Agonist-VK2735"},{"key":"e_1_3_4_121_1","doi-asserted-by":"publisher","DOI":"10.2337\/db23-763-P"},{"key":"e_1_3_4_122_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2021.174635"},{"key":"e_1_3_4_123_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2020.104492"},{"key":"e_1_3_4_124_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.peptides.2023.171003"},{"key":"e_1_3_4_125_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-008-7479-6"},{"key":"e_1_3_4_126_1","doi-asserted-by":"publisher","DOI":"10.1080\/13543776.2020.1769600"},{"key":"e_1_3_4_127_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20163905"},{"key":"e_1_3_4_128_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.1993.264.1.R116"},{"key":"e_1_3_4_129_1","doi-asserted-by":"publisher","DOI":"10.1016\/0031-9384(84)90160-4"},{"key":"e_1_3_4_130_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20215407"},{"key":"e_1_3_4_131_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.peptides.2020.170434"},{"key":"e_1_3_4_132_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2022.07.013"},{"key":"e_1_3_4_133_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2301972"},{"issue":"1","key":"e_1_3_4_134_1","article-title":"982-P: a double-blinded, placebo controlled, single ascending dose study for safety, tolerability, pharmacokinetics, and pharmacodynamics after subcutaneous administration of novel long-acting GLP-1\/GIP\/Glucagon triple agonist (HM15211) in healthy obese subjects","volume":"68","author":"Choi JD","year":"2019","unstructured":"Choi JD, Baek S, Y KIM, et al. 982-P: a double-blinded, placebo controlled, single ascending dose study for safety, tolerability, pharmacokinetics, and pharmacodynamics after subcutaneous administration of novel long-acting GLP-1\/GIP\/Glucagon triple agonist (HM15211) in healthy obese subjects. Diabetes. 2019;68(Supplement_1).","journal-title":"Diabetes"},{"key":"e_1_3_4_135_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2023.107176"},{"key":"e_1_3_4_136_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2021.12.005"},{"key":"e_1_3_4_137_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2023.155433"},{"key":"e_1_3_4_138_1","doi-asserted-by":"publisher","DOI":"10.1038\/s42255-023-00966-w"},{"key":"e_1_3_4_139_1","unstructured":"Bayer M. 9 Meters calls it quits after measuring options reports just $150K in cash. Fierce Biotech; 2023. Available from: https:\/\/www.fiercebiotech.com\/biotech\/9-meters-calls-it-quits-after-measuring-options-reports-just-150k-cash"},{"key":"e_1_3_4_140_1","unstructured":"9 meters biopharma announces successful pre-IND meeting with FDA regarding its GIP antagonist NM-136 for obesity [Internet]. Raleigh (NC); 2023 Apr 5. Available from: https:\/\/www.biospace.com\/article\/releases\/9-meters-biopharma-announces-successful-pre-ind-meeting-with-fda-regarding-its-gip-antagonist-nm-136-for-obesity\/"},{"key":"e_1_3_4_141_1","unstructured":"GMA106: gmax biopharm. [cited 2024 Feb 25]. Available from: https:\/\/www.gmaxbiopharm.com\/wap_product_detailen\/id\/6.html"},{"key":"e_1_3_4_142_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.peptides.2019.170208"},{"key":"e_1_3_4_143_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2028395"},{"key":"e_1_3_4_144_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2032183"},{"key":"e_1_3_4_145_1","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/3361309"},{"key":"e_1_3_4_146_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2017.11.003"},{"key":"e_1_3_4_147_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2022.101586"}],"container-title":["Expert Opinion on Investigational Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13543784.2024.2377319","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T15:49:16Z","timestamp":1727279356000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13543784.2024.2377319"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,17]]},"references-count":145,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8,2]]}},"alternative-id":["10.1080\/13543784.2024.2377319"],"URL":"https:\/\/doi.org\/10.1080\/13543784.2024.2377319","relation":{},"ISSN":["1354-3784","1744-7658"],"issn-type":[{"value":"1354-3784","type":"print"},{"value":"1744-7658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,17]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieid20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieid20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-03-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-03","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}